Analysis of Systematic Reviews in Clinical Practice Guidelines for Head and Neck Cancer

Ref ID 864
First Author J. Dhillon
Journal LARYNGOSCOPE
Year Of Publishing 2022
URL https://onlinelibrary.wiley.com/doi/10.1002/lary.30051
Keywords Publication bias
Oncology
Disclosure
Low reporting quality
Problem(s) Funding or sponsor of systematic review not reported
Low reporting (PRISMA) quality
Low methodological (AMSTAR) quality
Poor consideration of publication bias
Cochrane reviews more rigorous/higher quality than non-Cochrane reviews
Number of systematic reviews included 142
Summary of Findings From 142 systematic reviews underpinning clinical practice guidelines of management of head and neck cancer published between January 2017 and May 2021. A total of 16 Clinical Practive Guidlines (CPGs) and 142 unique Systematic Reviews were included. PRISMA completion ranged from 67.15% to 87.65% across CPGs with a mean of 76.41% (SD = 16.9). AMSTAR-2 completion ranged from 34.38% to 84.38% across CPGs with a mean of 67.55% (SD = 20.9) among all SRs. The lowest rated items included funding sources and publication bias. A higher score was achieved in Cochrane Systematic Reviews but they only accounted for 2.11% (3/142) of all Systematic Reviews.
Did the article find that the problem(s) led to qualitative changes in interpretation of the results? Not Applicable
Are the methods of the article described in enough detail to replicate the study? No